I read with interest the paper by Cho et al. [(1)][1] , which demonstrates that serum amyloid A protein (SAA) may be a potentially useful biomarker for nasopharyngeal carcinoma. The authors discovered this biomarker by using serum proteomic profiling with the so-called SELDI-TOF-MS technology (
No takes yet. Share an insight, caveat, or question.
Eleftherios P. Diamandis (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: